Chronic oscillating glucose challenges disarrange innate immune homeostasis to potentiate the variation of neutrophil–lymphocyte ratio in rats with or without hidden diabetes mellitus

References

• Saraheimo M Teppo AM Forsblom C Fagerudd J Groop PH Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients Diabetologia 2003 46 1402 1407 12928771
   PubMed Web of Science ®Google Scholar
• DiGangi C Neutrophil-lymphocyte ratio: Predicting cardiovascular and renal complications in patients with diabetes J Am Assoc Nurse Pract 2016 28 410 414 27092809
   PubMed Web of Science ®Google Scholar
• Mantovani A Cassatella MA Costantini C Jaillon S Neutrophils in the activation and regulation of innate and adaptive immunity Nat Rev Immunol 2011 11 519 531 21785456
   PubMed Web of Science ®Google Scholar
• Jackson MH Collier A Nicoll JJ Neutrophil count and activation in vascular disease Scott Med J 1992 37 41 43 1609264
   PubMed Web of Science ®Google Scholar
• Collier A Jackson M Bell D Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus Diabetes Res 1989 10 135 138 2805587
   PubMedGoogle Scholar
• Valle A Giamporcaro GM Scavini M Reduction of circulating neutrophils precedes and accompanies type 1 diabetes Diabetes 2013 62 2072 2077 23349491
   PubMed Web of Science ®Google Scholar
• Harsunen MH Puff R D’Orlando O Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes Horm Metab Res 2013 45 467 470 23322517
   PubMed Web of Science ®Google Scholar
• Cohen JJ Duke RC Fadok VA Sellins KS Apoptosis and programmed cell death in immunity Annu Rev Immunol 1992 10 267 293 1590988
   PubMed Web of Science ®Google Scholar
• Colucci F Bergman ML Penha-Gonçalves C Cilio CM Holmberg D Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region Proc Natl Acad Sci U S A 1997 94 8670 8674 9238035
   PubMed Web of Science ®Google Scholar
• Jailer JW Marks DT Marks PA Variations in white blood cells following the oral administration of glucose to diabetics and nondiabetics J Clin Endocrinol Metab 1948 8 1074 1080 18109117
   PubMed Web of Science ®Google Scholar
• Xu H Chen Y Li Y Mitochondrial apoptosis of lymphocyte is induced in type 2 diabetes Chin Med J (Engl) 2014 127 213 217 24438606
   PubMed Web of Science ®Google Scholar
• King AJ The use of animal models in diabetes research Br J Pharmacol 2012 166 877 894 22352879
   PubMed Web of Science ®Google Scholar
• Wang J Wan R Mo Y Zhang Q Sherwood LC Chien S Creating a long-term diabetic rabbit model Exp Diabetes Res 2010 2010 289614 21234414
   PubMedGoogle Scholar
• Federiuk IF Casey HM Quinn MJ Wood MD Ward WK Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment Comp Med 2004 54 252 257 15253270
   PubMed Web of Science ®Google Scholar
• Kolb H Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice Diabetes Metab Rev 1987 3 751 778 2956075
   PubMed Web of Science ®Google Scholar
• Matsumoto K Ochiai T Sekita K Kawasaki Y Yasuhara K Furuya T Application of an automatic blood cell counter, MICROX, to experimental animals. II. Leukocyte differential count in rabbits, rats, and mice Jikken Dobutsu 1983 32 115 122 6653678
   PubMed Web of Science ®Google Scholar
• Papasouliotis K Cue S Crawford E Pinches M Dumont M Burley K Comparison of white blood cell differential percentages determined by the in-house LaserCyte hematology analyzer and a manual method Vet Clin Pathol 2006 35 295 302 16967412
   PubMed Web of Science ®Google Scholar
• Kraynak AR Storer RD Jensen RD Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays Toxicol Appl Pharmacol 1995 135 279 286 8545838
   PubMed Web of Science ®Google Scholar
• Park SK Kang SK Renal function and hemodynamic study in obese Zucker rats Korean J Intern Med 1995 10 48 53 7626557
   PubMedGoogle Scholar
• Li M Naqvi N Yahiro E c-kit is required for cardiomyocyte terminal differentiation Circ Res 2008 102 677 685 18258857
   PubMed Web of Science ®Google Scholar
• Ceriello A Esposito K Piconi L Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients Diabetes 2008 57 1349 1354 18299315
   PubMed Web of Science ®Google Scholar
• Azab B Chainani V Shah N McGinn JT Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study Angiology 2013 64 456 465 22904109
   PubMed Web of Science ®Google Scholar
• Azab B Daoud J Naeem FB Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study) Ren Fail 2012 34 571 576 22452450
   PubMed Web of Science ®Google Scholar
• Mertoglu C Gunay M Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus Diabetes Metab Syndr 2016 11 Suppl 1 S127 S131 28017281
   PubMed Web of Science ®Google Scholar
• Huang J Xiao Y Xu A Zhou Z Neutrophils in type 1 diabetes J Diabetes Investig 2016 7 652 663
   Web of Science ®Google Scholar
• Winiarska K Szymanski K Gorniak P Dudziak M Bryla J Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits Biochimie 2009 91 261 270 18957317
   PubMed Web of Science ®Google Scholar
• Szkudelski T The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol Res 2001 50 537 546 11829314
   PubMed Web of Science ®Google Scholar
• Meehan CJ Davidson PM Young DG Foulis AK The partially diabetic pancreas: a histological study of a new animal model Pancreas 1987 2 91 98 3554226
   PubMedGoogle Scholar
• Papadopoulou-Marketou N Chrousos GP Kanaka-Gantenbein C Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis Diabetes Metab Res Rev 2017 33 e2841 Epub 2016 Oct 4
   Web of Science ®Google Scholar
• Palsamy P Subramanian S Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling Biochim Biophys Acta 2011 1812 719 731 21439372
   PubMed Web of Science ®Google Scholar